Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hansjakob Furrer

Showing results (1-10 of 303) with videos related to

Pageof 31
Sort By:
The Journal of Infectious Diseases|August 26, 2016
Opportunistic Diseases During HIV Infection-Things Aren't What They Used to Be, or Are They?Hansjakob Furrer
BMJ Case Reports|November 26, 2014
Chameleons everywhereKatharina Sprenger, Hansjakob Furrer
Therapeutische Umschau. Revue Therapeutique|November 25, 2003
["Viral infection"]Hansjakob Furrer, Peter Erb
Journal of HIV Therapy|April 17, 2002
Opportunistic infections: an updateHansjakob Furrer, Christoph Fux
The Lancet. Infectious Diseases|March 18, 2020
Think tuberculosis-but is thinking enough?Peter M Keller, Hansjakob Furrer
AIDS (London, England)|November 10, 2011
Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patientGilles Wandeler, Hansjakob Furrer, Andri Rauch
Therapeutische Umschau. Revue Therapeutique|October 27, 2021
[Sexually transmitted anorectal infections]Bernard Surial, Manfred Essig, Hansjakob Furrer
The World Allergy Organization Journal|January 4, 2013
Specific immunotherapy in a pollen-allergic patient with human immunodeficiency virus infectionUrs C Steiner, Hansjakob Furrer, Arthur Helbling
BMC Research Notes|May 3, 2020
Is real time PCR preferable to the direct immunofluorescence in the diagnosis of Pneumocystis jirovecii pneumonia in HIV-infected patients?Simon Bossart, Konrad Mühlethaler, Christian Garzoni, et al.
Therapeutische Umschau. Revue Therapeutique|June 9, 2016
[Vaccinations for immunocompromised hosts – focussing on patients after a hematological stem cell or organ transplantation, with HIV or with functional or anatomical asplenia]Cornelia Staehelin, Cédric Hirzel, Christoph Hauser, et al.
Pageof 31

Showing results (1-10 of 303) with videos related to

Sort By:
Pageof 31
The Journal of Infectious Diseases|August 26, 2016
Opportunistic Diseases During HIV Infection-Things Aren't What They Used to Be, or Are They?Hansjakob Furrer
BMJ Case Reports|November 26, 2014
Chameleons everywhereKatharina Sprenger, Hansjakob Furrer
Therapeutische Umschau. Revue Therapeutique|November 25, 2003
["Viral infection"]Hansjakob Furrer, Peter Erb
Journal of HIV Therapy|April 17, 2002
Opportunistic infections: an updateHansjakob Furrer, Christoph Fux
The Lancet. Infectious Diseases|March 18, 2020
Think tuberculosis-but is thinking enough?Peter M Keller, Hansjakob Furrer
AIDS (London, England)|November 10, 2011
Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patientGilles Wandeler, Hansjakob Furrer, Andri Rauch
Therapeutische Umschau. Revue Therapeutique|October 27, 2021
[Sexually transmitted anorectal infections]Bernard Surial, Manfred Essig, Hansjakob Furrer
The World Allergy Organization Journal|January 4, 2013
Specific immunotherapy in a pollen-allergic patient with human immunodeficiency virus infectionUrs C Steiner, Hansjakob Furrer, Arthur Helbling
BMC Research Notes|May 3, 2020
Is real time PCR preferable to the direct immunofluorescence in the diagnosis of Pneumocystis jirovecii pneumonia in HIV-infected patients?Simon Bossart, Konrad Mühlethaler, Christian Garzoni, et al.
Therapeutische Umschau. Revue Therapeutique|June 9, 2016
[Vaccinations for immunocompromised hosts – focussing on patients after a hematological stem cell or organ transplantation, with HIV or with functional or anatomical asplenia]Cornelia Staehelin, Cédric Hirzel, Christoph Hauser, et al.
Pageof 31